These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 23856067)
1. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator. Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067 [TBL] [Abstract][Full Text] [Related]
2. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Thiex R; Küker W; Müller HD; Rohde I; Schröder JM; Gilsbach JM; Rohde V Neurol Res; 2003 Apr; 25(3):254-62. PubMed ID: 12739233 [TBL] [Abstract][Full Text] [Related]
3. The role of endogenous versus exogenous tPA on edema formation in murine ICH. Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833 [TBL] [Abstract][Full Text] [Related]
4. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke. El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458 [TBL] [Abstract][Full Text] [Related]
5. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Mould WA; Carhuapoma JR; Muschelli J; Lane K; Morgan TC; McBee NA; Bistran-Hall AJ; Ullman NL; Vespa P; Martin NA; Awad I; Zuccarello M; Hanley DF; Stroke; 2013 Mar; 44(3):627-34. PubMed ID: 23391763 [TBL] [Abstract][Full Text] [Related]
6. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry. Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711 [TBL] [Abstract][Full Text] [Related]
7. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
8. Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. Lee ST; Chu K; Jung KH; Kim J; Kim EH; Kim SJ; Sinn DI; Ko SY; Kim M; Roh JK J Cereb Blood Flow Metab; 2006 Apr; 26(4):536-44. PubMed ID: 16107786 [TBL] [Abstract][Full Text] [Related]
9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related]
10. In Models of Intracerebral Hemorrhage, Rivaroxaban is Superior to Warfarin to Limit Blood Brain Barrier Disruption and Hematoma Expansion. Sawada S; Ono Y; Egashira Y; Takagi T; Tsuruma K; Shimazawa M; Iwama T; Hara H Curr Neurovasc Res; 2017; 14(2):96-103. PubMed ID: 27993122 [TBL] [Abstract][Full Text] [Related]
11. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH. Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263 [TBL] [Abstract][Full Text] [Related]
12. Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke? Kimura K; Sakai K; Iguchi Y; Shibazaki K; Sakamoto Y Eur Neurol; 2011; 65(5):245-9. PubMed ID: 21464569 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model. Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats. Deinsberger W; Vogel J; Fuchs C; Auer LM; Kuschinsky W; Böker DK Neurol Res; 1999 Jul; 21(5):517-23. PubMed ID: 10439435 [TBL] [Abstract][Full Text] [Related]
16. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581 [TBL] [Abstract][Full Text] [Related]
17. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. Wagner KR; Xi G; Hua Y; Zuccarello M; de Courten-Myers GM; Broderick JP; Brott TG J Neurosurg; 1999 Mar; 90(3):491-8. PubMed ID: 10067918 [TBL] [Abstract][Full Text] [Related]
18. Risk of intracerebral hemorrhage after thrombolysis in patients with asymptomatic hemorrhage on T2*. Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Kimura K Cerebrovasc Dis; 2014; 38(2):107-16. PubMed ID: 25277866 [TBL] [Abstract][Full Text] [Related]
19. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742 [TBL] [Abstract][Full Text] [Related]
20. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits]. Schaller C; Rohde V; Hassler W Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]